X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2210) 2210
Publication (227) 227
Book Review (20) 20
Book Chapter (4) 4
Dissertation (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1476) 1476
male (1132) 1132
index medicus (1017) 1017
animals (1010) 1010
female (898) 898
isoxazoles - pharmacology (891) 891
isoxazoles - therapeutic use (720) 720
adult (531) 531
pharmacology & pharmacy (502) 502
middle aged (494) 494
rats (431) 431
isoxazoles - administration & dosage (414) 414
isoxazoles - adverse effects (387) 387
mice (351) 351
leflunomide (343) 343
treatment outcome (306) 306
isoxazoles - blood (296) 296
aged (276) 276
isoxazoles - pharmacokinetics (271) 271
dose-response relationship, drug (255) 255
paliperidone palmitate (253) 253
efficacy (204) 204
arthritis, rheumatoid - drug therapy (190) 190
pharmacokinetics (186) 186
adolescent (183) 183
risperidone (183) 183
psychiatry (181) 181
drug therapy (175) 175
double-blind (174) 174
administration, oral (173) 173
research (173) 173
rheumatology (173) 173
drug therapy, combination (171) 171
neurosciences (170) 170
time factors (166) 166
analysis (164) 164
schizophrenia (158) 158
clinical neurology (156) 156
rheumatoid arthritis (149) 149
schizophrenia - drug therapy (148) 148
zonisamide (148) 148
safety (147) 147
expression (146) 146
double-blind method (143) 143
immunology (143) 143
care and treatment (142) 142
biochemistry & molecular biology (139) 139
dogs (138) 138
isoxazoles - chemistry (137) 137
surgery (136) 136
rats, sprague-dawley (133) 133
medicine & public health (131) 131
young adult (130) 130
immunosuppressive agents - therapeutic use (126) 126
antipsychotic agents - therapeutic use (120) 120
pyrimidines - blood (119) 119
disease models, animal (117) 117
antipsychotic agents - adverse effects (116) 116
antirheumatic agents - therapeutic use (116) 116
isoxazoles - metabolism (112) 112
metabolism (112) 112
health aspects (109) 109
cells, cultured (108) 108
methotrexate (106) 106
antipsychotic agents - pharmacokinetics (105) 105
cell biology (105) 105
inhibition (104) 104
mice, inbred c57bl (104) 104
transplantation (104) 104
therapy (101) 101
drug interactions (97) 97
isoxazoles (97) 97
rheumatoid-arthritis (95) 95
rats, wistar (94) 94
inflammation (92) 92
risperidone - blood (91) 91
chemistry, medicinal (90) 90
drugs (90) 90
anticonvulsants - therapeutic use (89) 89
child (89) 89
antipsychotic agents - administration & dosage (87) 87
article (87) 87
toxicology (87) 87
activation (82) 82
antipsychotic agents - blood (82) 82
drug administration schedule (81) 81
cell line, tumor (80) 80
pharmacology/toxicology (80) 80
dosage and administration (79) 79
epilepsy (79) 79
internal medicine (79) 79
methotrexate - therapeutic use (79) 79
physiological aspects (79) 79
in-vitro (78) 78
risperidone - pharmacokinetics (77) 77
9-hydroxyrisperidone (75) 75
research article (75) 75
prospective studies (74) 74
oncology (73) 73
pharmacology (71) 71
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2187) 2187
Japanese (26) 26
Chinese (11) 11
German (6) 6
French (3) 3
Italian (3) 3
Spanish (2) 2
Danish (1) 1
Hungarian (1) 1
Polish (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 06/2017, Volume 37, Issue 8, pp. 1482 - 1493
Journal Article
Forensic Science International, ISSN 0379-0738, 2013, Volume 229, Issue 1, pp. 145 - 150
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2015, Volume 10, Issue 4, p. e0124352
Kidneys and lungs are the most common organs involved in microscopic polyangiitis (MPA). A retrospective analysis of pediatric MPA patients with pulmonary... 
ANTINEUTROPHIL CYTOPLASMIC ANTIBODY | WEGENERS-GRANULOMATOSIS | MAINTENANCE | ANCA-POSITIVE VASCULITIS | MULTIDISCIPLINARY SCIENCES | INVOLVEMENT | ALVEOLAR HEMORRHAGE | CLASSIFICATION | LEFLUNOMIDE | PATHOLOGICAL FEATURES | REMISSION | Hemoptysis - pathology | Kidney - pathology | Anemia - blood | Cough - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Child, Preschool | Tachypnea - pathology | Anemia - pathology | Infant | Male | Proteinuria - pathology | Cyclophosphamide - therapeutic use | Proteinuria - blood | Tachypnea - blood | Kidney - metabolism | Anemia - drug therapy | Hematuria - drug therapy | Hemoptysis - drug therapy | Anti-Inflammatory Agents - therapeutic use | Female | Lung - metabolism | Steroids - therapeutic use | Child | Lung - pathology | Kidney - drug effects | Tachypnea - drug therapy | Complement C3 - metabolism | Treatment Outcome | Cough - blood | Microscopic Polyangiitis - blood | Hematuria - blood | Cough - pathology | Proteinuria - drug therapy | Lung - drug effects | Adolescent | Microscopic Polyangiitis - drug therapy | Isoxazoles - therapeutic use | Microscopic Polyangiitis - pathology | Peroxidase - blood | Hematuria - pathology | Hemoptysis - blood | Antibodies, Antineutrophil Cytoplasmic - blood | Pediatrics | Pneumonia | Tachypnea | Proteinase | Medical services | Systematic review | Leflunomide | Hemorrhage | Renal insufficiency | Hemoptysis | Histopathology | Pulmonary lesions | Antineutrophil cytoplasmic antibodies | Remission | Peroxidase | Children | Capillaries | Alveoli | Antinuclear antibodies | Deoxyribonucleic acid--DNA | Kidneys | Hematuria | Anemia | Rheumatology | Organs | Patients | Girls | Cough | Pathology | Cyclophosphamide | Pulmonary fibrosis | Lungs | Complement component C3 | Exudation | Kidney diseases | Proteinase 3 | Proteinuria | Kidney transplantation | Deoxyribonucleic acid | DNA
Journal Article
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 12/2016, Volume 36, Issue 12, pp. 2324 - 2333
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 01/2015, Volume 746, pp. 301 - 307
Zonisamide has been reported to have protective effects on epilepsy and Parkinson׳s disease and to work via various mechanisms of action, such as inhibition of... 
Parkinson׳s disease | Endoplasmic reticulum stress | Zonisamide | Parkinson's disease | APOPTOSIS | ISCHEMIA | IMPAIRMENT | INHIBITION | INFLAMMATION | CALCIUM | DOPAMINE | CHOP | PHARMACOLOGY & PHARMACY | PARKINSON-DISEASE | Neuroprotective Agents - therapeutic use | Neurons - pathology | Antiparkinson Agents - pharmacology | Substantia Nigra - pathology | Humans | Thapsigargin - antagonists & inhibitors | Half-Life | Male | MPTP Poisoning - blood | Substantia Nigra - metabolism | Tunicamycin - antagonists & inhibitors | Anticonvulsants - pharmacology | Antiparkinson Agents - therapeutic use | Neuroprotective Agents - pharmacology | Neuroprotective Agents - pharmacokinetics | Isoxazoles - blood | Neurons - metabolism | Parkinson Disease - metabolism | Cell Death - drug effects | Neurons - drug effects | Thapsigargin - toxicity | Disease Models, Animal | Isoxazoles - pharmacokinetics | Cell Survival - drug effects | Anticonvulsants - blood | Anticonvulsants - pharmacokinetics | Parkinson Disease - pathology | Tunicamycin - toxicity | Endoplasmic Reticulum Stress - drug effects | Mice, Inbred C57BL | Anticonvulsants - therapeutic use | MPTP Poisoning - prevention & control | Antiparkinson Agents - pharmacokinetics | Isoxazoles - pharmacology | Neuroprotective Agents - blood | Parkinson Disease - prevention & control | Substantia Nigra - drug effects | Animals | Antiparkinson Agents - blood | Cell Line, Tumor | Isoxazoles - therapeutic use | Parkinson Disease - blood | Anticonvulsants | Stress (Physiology) | Monoamine oxidase | Neurons | Analysis | Epilepsy
Journal Article
Journal Article